Clinical Trial Update: The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating tranexamic acid to reduce transfusion rates in intertrochanteric hip fractures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture
• Intertrochanteric Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Hip Fracture, Blood Loss | Phase 4 | Status: WITHDRAWN